Just like the rest of evolution in Mother Nature, the evolution of cancers may be driven by natural selection, and not by haphazard mutations

Sporadic carcinogenesis starts from immortalization of a differentiated somatic cell or an organ-specific stem cell. The immortalized cell incepts a new or quasinew organism that lives like a parasite in the patient and usually proceeds to progressive simplification, constantly engendering intermediate organisms that are simpler than normal cells. Like organismal evolution in Mother Nature, this cellular simplification is a process of Darwinian selection of those mutations with growth- or survival-advantages, from numerous ones that occur randomly and stochastically. Therefore, functional gain of growth- or survival-sustaining oncogenes and functional loss of differentiation-sustaining tumor suppressor genes, which are hallmarks of cancer cells and contribute to phenotypes of greater malignancy, are not drivers of carcinogenesis but are results from natural selection of advantageous mutations. Besides this mutation-load dependent survival mechanism that is evolutionarily low and of an asexual nature, cancer cells may also use cell fusion for survival, which is an evolutionarily-higher mechanism and is of a sexual nature. Assigning oncogenes or tumor suppressor genes or their mutants as drivers to induce cancer in animals may somewhat coerce them to create man-made oncogenic pathways that may not really be a course of sporadic cancer formations in the human.

[1]  H. Burrows Carcinoma mammae occurring in a male mouse under continued treatment with oestrin. , 1935, The American journal of cancer.

[2]  J. Jonkers,et al.  Molecular Pathways Molecular Pathways : How Can BRCA-Mutated Tumors Become Resistant to PARP Inhibitors ? , 2014 .

[3]  Andrew M. K. Brown,et al.  Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer , 2013, Science.

[4]  S. Subramanian,et al.  Significance of Population Size on the Fixation of Nonsynonymous Mutations in Genes Under Varying Levels of Selection Pressure , 2013, Genetics.

[5]  J. Platt,et al.  Biological implications of cell fusion , 2005, Nature Reviews Molecular Cell Biology.

[6]  C. Sonnenschein,et al.  Paradoxes in Carcinogenesis: There Is Light at the End of That Tunnel! , 2013, Disruptive science and technology.

[7]  C. Sonnenschein,et al.  The aging of the 2000 and 2011 Hallmarks of Cancer reviews: A critique , 2013, Journal of Biosciences.

[8]  C. Hartman,et al.  Tumors of the breast related to the oestrin hormone. , 1934, The American journal of cancer.

[9]  J. Huxley CANCER BIOLOGY: COMPARATIVE and GENETIC * , 1956 .

[10]  M. Blagosklonny Oncogenic resistance to growth-limiting conditions , 2002, Nature Reviews Cancer.

[11]  R. Noble,et al.  Mammary tumors of the rat: a review. , 1959, Cancer research.

[12]  P. J. Pretorius,et al.  Point mutation instability (PIN) mutator phenotype as model for true back mutations seen in hereditary tyrosinemia type 1 – a hypothesis , 2012, Journal of Inherited Metabolic Disease.

[13]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[14]  R. Rosenfeld Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[15]  Daniel Birnbaum,et al.  A cell cycle hypothesis of cooperative oncogenesis (Review). , 2007, International journal of oncology.

[16]  Peter Bouwman,et al.  The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance , 2012, Nature Reviews Cancer.

[17]  D. Goldenberg Horizontal transmission of malignancy by cell–cell fusion , 2012, Expert opinion on biological therapy.

[18]  B. Anokhin,et al.  Naturally occurring tumours in the basal metazoan Hydra , 2014, Nature Communications.

[19]  T. Ried,et al.  Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivo , 2012, International journal of cancer.

[20]  J. Pawelek Fusion of bone marrow-derived cells with cancer cells: metastasis as a secondary disease in cancer , 2014, Chinese journal of cancer.

[21]  Carlos Sonnenschein,et al.  One hundred years of somatic mutation theory of carcinogenesis: Is it time to switch? , 2014, BioEssays : news and reviews in molecular, cellular and developmental biology.

[22]  Siqi Liu,et al.  Necrosis, and then stress induced necrosis-like cell death, but not apoptosis, should be the preferred cell death mode for chemotherapy: clearance of a few misconceptions , 2014, Oncoscience.

[23]  S. Gestl,et al.  Tumor cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers , 2014, Nature.

[24]  P. Nowell The clonal evolution of tumor cell populations. , 1976, Science.

[25]  Prakash Kulkarni,et al.  Competing views on cancer , 2014, Journal of Biosciences.

[26]  R. Prehn,et al.  A new kink in an old theory of carcinogenesis , 2013, Theoretical Biology and Medical Modelling.

[27]  Jouni Uitto,et al.  Revertant mosaicism in skin: natural gene therapy. , 2011, Trends in molecular medicine.

[28]  J. Mallet Hybrid speciation , 2007, Nature.

[29]  P. Khavari,et al.  CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis , 2002, Nature Medicine.

[30]  Alan Ashworth,et al.  Drug resistance caused by reversion mutation. , 2008, Cancer research.

[31]  T. Jacks,et al.  Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma. , 2006, Cancer research.

[32]  S. Otto,et al.  Condition‐Dependent Sex and the Rate of Adaptation , 2009, The American Naturalist.

[33]  R. Prehn,et al.  Is an immune reaction required for malignant transformation and cancer growth? , 2012, Cancer Immunology, Immunotherapy.

[34]  M. Blagosklonny NCI's provocative questions on cancer: some answers to ignite discussion , 2011, Oncotarget.

[35]  A. Knudson,et al.  A continuum model for tumour suppression , 2011, Nature.

[36]  Christopher G. Wilson,et al.  Spatial and temporal escape from fungal parasitism in natural communities of anciently asexual bdelloid rotifers , 2013, Proceedings of the Royal Society B: Biological Sciences.

[37]  T. Tsang,et al.  A stem cell fusion model of carcinogenesis. , 2005, Journal of experimental therapeutics & oncology.

[38]  R. Weinberg Coming Full Circle—From Endless Complexity to Simplicity and Back Again , 2014, Cell.

[39]  K. Pienta,et al.  Evolution of cooperation among tumor cells , 2006, Proceedings of the National Academy of Sciences.

[40]  M. Blagosklonny Cell Immortality and Hallmarks of Cancer , 2003, Cell cycle.

[41]  Dean W. Felsher,et al.  Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation , 2007, Proceedings of the National Academy of Sciences.

[42]  A. Chakraborty,et al.  Leukocyte-cancer cell fusion: initiator of the warburg effect in malignancy? , 2011, Advances in experimental medicine and biology.

[43]  T. Rando,et al.  The mortal strand hypothesis: non-random chromosome inheritance and the biased segregation of damaged DNA. , 2013, Seminars in cell & developmental biology.

[44]  H. Heng,et al.  The evolutionary mechanism of cancer , 2010, Journal of cellular biochemistry.

[45]  K. Polyak,et al.  Cancer: Clonal cooperation , 2014, Nature.

[46]  S. Subramanian Fixation of deleterious mutations at critical positions in human proteins. , 2011, Molecular biology and evolution.

[47]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[48]  C. Lively,et al.  Exposure to parasites increases promiscuity in a freshwater snail , 2014, Biology Letters.

[49]  K. Young,et al.  Incorporating pathologists' criteria of malignancy into the evolutionary model for cancer development , 2004, Journal of cellular biochemistry.

[50]  A. Knudson,et al.  Two genetic hits (more or less) to cancer , 2001, Nature Reviews Cancer.

[51]  M. Goddard,et al.  Sex enhances adaptation by unlinking beneficial from detrimental mutations in experimental yeast populations , 2012, BMC Evolutionary Biology.

[52]  M. Wong,et al.  Genetic basis of cell-cell fusion mechanisms. , 2013, Trends in genetics : TIG.

[53]  R. Dickson,et al.  Roles of androgens in the development, growth, and carcinogenesis of the mammary gland , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[54]  E. Pennisi Genomics. ENCODE project writes eulogy for junk DNA. , 2012, Science.

[55]  D. Peeper,et al.  The essence of senescence. , 2010, Genes & development.

[56]  Siqi Liu,et al.  The other side of the coin: The tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND–CDK4/6–RB axis , 2014, Cell cycle.

[57]  Paulo P. Amaral,et al.  The Reality of Pervasive Transcription , 2011, PLoS biology.

[58]  A. Gudkov,et al.  Elimination of Proliferating Cells Unmasks the Shift from Senescence to Quiescence Caused by Rapamycin , 2011, PloS one.

[59]  John Cairns,et al.  Mutation selection and the natural history of cancer , 1975, Nature.

[60]  R. Sachs,et al.  Chromosomal alterations cause the high rates and wide ranges of drug resistance in cancer cells. , 2005, Cancer genetics and cytogenetics.

[61]  From aneuploidy to cancer: The evolution of a new species? , 2012, Journal of Biosciences.

[62]  D. Felsher,et al.  Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programs. , 2013, Advances in experimental medicine and biology.

[63]  S. Gabriel,et al.  Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.

[64]  D. García-Olmo,et al.  Transformation of non-tumor host cells during tumor progression: theories and evidence , 2012, Expert opinion on biological therapy.

[65]  Batoul Y. Abdallah,et al.  Genome chaos: Survival strategy during crisis , 2014, Cell cycle.

[66]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[67]  L. Chung,et al.  Spontaneous Cancer-Stromal Cell Fusion as a Mechanism of Prostate Cancer Androgen-Independent Progression , 2012, PloS one.

[68]  J. Belizário The humankind genome: from genetic diversity to the origin of human diseases. , 2013, Genome.

[69]  C. Mceuen Occurrence of cancer in rats treated with oestrone. , 1938, The American journal of cancer.

[70]  Y. Yamashita,et al.  DNA asymmetry in stem cells – immortal or mortal? , 2013, Journal of Cell Science.

[71]  Christopher R. Jones,et al.  Sex increases the efficacy of natural selection in experimental yeast populations , 2005, Nature.

[72]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[73]  G. Barry,et al.  The emerging role of RNA and DNA editing in cancer. , 2014, Biochimica et biophysica acta.

[74]  R. Noble,et al.  Spontaneous and estrogen-produced tumors in Nb rats and their behavior after transplantation. , 1975, Cancer research.

[75]  J. Settleman,et al.  From Cancer Genomics to Precision Oncology—Tissue’s Still an Issue , 2014, Cell.

[76]  Wei Duan,et al.  Cancer stem cells: A contentious hypothesis now moving forward. , 2014, Cancer letters.

[77]  G. Vereb,et al.  Die hard: Are cancer stem cells the Bruce Willises of tumor biology? , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[78]  M. Cragg,et al.  Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal , 2013, Cancer Cell International.

[79]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[80]  J. Uitto,et al.  Revertant mosaicism in heritable skin diseases: mechanisms of natural gene therapy. , 2012, Discovery medicine.

[81]  M. Lisanti,et al.  Reviewing once more the c-myc and Ras collaboration , 2011, Cell cycle.

[82]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[83]  M. Lisanti,et al.  c-Myc induction of programmed cell death may contribute to carcinogenesis , 2011, Cancer biology & therapy.

[84]  Y. Lazebnik,et al.  Cell fusion: a hidden enemy? , 2003, Cancer cell.

[85]  G. Clawson Fusion for Moving , 2013, Science.

[86]  Alan Ashworth,et al.  Stem cells and breast cancer: A field in transit , 2003, Nature Reviews Cancer.

[87]  Kornelia Polyak,et al.  Cancer Cell Phenotypes, in Fifty Shades of Grey , 2013, Science.

[88]  T. Shlomi,et al.  A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence , 2013, Nature.

[89]  S. Subramanian Quantifying harmful mutations in human populations , 2012, European Journal of Human Genetics.

[90]  J. Shendure,et al.  Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.

[91]  E. Ben-Jacob,et al.  Bacterial survival strategies suggest rethinking cancer cooperativity. , 2012, Trends in microbiology.

[92]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .

[93]  C. Lineweaver,et al.  Cancer tumors as Metazoa 1.0: tapping genes of ancient ancestors , 2011, Physical biology.

[94]  E. Swisher,et al.  Secondary mutations of BRCA1/2 and drug resistance , 2011, Cancer science.

[95]  J. M. Nicholson,et al.  Is carcinogenesis a form of speciation? , 2011, Cell cycle.

[96]  Mark D Vincent,et al.  Cancer: beyond speciation. , 2011, Advances in cancer research.

[97]  Batoul Y. Abdallah,et al.  Evolutionary mechanisms and diversity in cancer. , 2011, Advances in cancer research.

[98]  D. Schwarz,et al.  A NOVEL PREFERENCE FOR AN INVASIVE PLANT AS A MECHANISM FOR ANIMAL HYBRID SPECIATION , 2007, Evolution; international journal of organic evolution.

[99]  E. Jaffe,et al.  Horizontal Transmission of Malignancy: In-Vivo Fusion of Human Lymphomas with Hamster Stroma Produces Tumors Retaining Human Genes and Lymphoid Pathology , 2013, PloS one.

[100]  R. Noble Sex steroids as a cause of adenocarcinoma of the dorsal prostate in Nb rats, and their influence on the growth of transplants. , 1977, Oncology.

[101]  A. Hidalgo-Miranda,et al.  Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model , 2012, PloS one.

[102]  M. Blagosklonny,et al.  Molecular theory of cancer , 2005, Cancer biology & therapy.

[103]  Henry H. Heng,et al.  Chromosomal instability (CIN): what it is and why it is crucial to cancer evolution , 2013, Cancer and Metastasis Reviews.

[104]  P. Johnston,et al.  Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.

[105]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[106]  Philip Campbell,et al.  Presenting ENCODE , 2012, Nature.

[107]  T. Seyfried,et al.  On the origin of cancer metastasis. , 2013, Critical reviews in oncogenesis.

[108]  L. Becks,et al.  Higher rates of sex evolve in spatially heterogeneous environments , 2010, Nature.

[109]  D. Grignon,et al.  Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancer. , 2007, Histology and histopathology.

[110]  C. Zimmer Origins. On the origin of sexual reproduction. , 2009, Science.

[111]  Meital Oren-Suissa,et al.  Evolution of programmed cell fusion: Common mechanisms and distinct functions , 2010, Developmental dynamics : an official publication of the American Association of Anatomists.

[112]  Kavya Rakhra,et al.  Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction , 2011, Proceedings of the National Academy of Sciences.

[113]  Dean W. Felsher,et al.  Combined Inactivation of MYC and K-Ras Oncogenes Reverses Tumorigenesis in Lung Adenocarcinomas and Lymphomas , 2008, PloS one.

[114]  R T Prehn,et al.  Cancers beget mutations versus mutations beget cancers. , 1994, Cancer research.

[115]  P. Vineis,et al.  The population dynamics of cancer: a Darwinian perspective. , 2006, International journal of epidemiology.

[116]  R. Noble Production of Nb rat carcinoma of the dorsal prostate and response of estrogen-dependent transplants to sex hormones and tamoxifen. , 1980, Cancer research.

[117]  J. Cairns,et al.  Cancer and the Immortal Strand Hypothesis , 2006, Genetics.

[118]  R. Hirschhorn In vivo reversion to normal of inherited mutations in humans , 2003, Journal of medical genetics.

[119]  Adrian Carr,et al.  Biochemical Diversification through Foreign Gene Expression in Bdelloid Rotifers , 2012, PLoS genetics.